⌘K

Login Start Free

Home/Filings/4/0000950170-24-073256

4//SEC Filing

Lee David K 4

Accession 0000950170-24-073256

CIK 0001808865other

View on SEC.gov Company Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 8:00 PM ET

Size

5.0 KB

Accession

0000950170-24-073256

Insider Transaction Report

Form 4

Period: 2024-06-11

iTeos Therapeutics, Inc.ITOS

Director

Transactions

Award
Stock Option (Right to Buy)
2024-06-11+24,200→ 24,200 total
Exercise: $16.32From: 2025-06-11Exp: 2034-06-11→ Common Stock (24,200 underlying)

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1

filerCIK 0002002238

Filing Metadata

Form type: 4
Filed: Jun 12, 8:00 PM ET
Accepted: Jun 13, 8:00 PM ET
Size: 5.0 KB

View on SEC.gov